Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Vectura Group PLC Add to portfolio

FTAL:VEC, Jul 17, 07:31 UTC

Latest FTAL:VEC News

Filter your feed

Apply Filter

Today


News

Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pre-close trading update

VEC

Chippenham, UK – 17 July 2019: Vectura Group plc (VEC.L) ("Vectura" or "the Group") today confirms its R&D investment priorities, announces a proposed £50 million capital return and provides an unaudited pre-close trading update. “Given the Group’s focus is now primarily on organic growth, with lower risk R&D spend supported by partners, it is our intention to return £50 million to shareholders this year, with the Board continuing to review our capital allocation strategy on a regular basis. Following the successful build out of its generics portfolio, Vectura will continue to focus on securing new partner contracts for the development of inhaled therapies, including novel molecules. For these contracts the Group will move towards offering development services where a smaller proportion of the overall contract value is delivered through contingent milestones. In light of the Group’s reducing R&D risk profile, future cash generation expectations and strong cash balance, the Board has approved, in principle, a capital return of approximately £50 million, commencing in 2019.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, July 06


News

Vectura Group PLC (LON:VEC) Given Consensus Recommendation of “Buy” by Analysts – Mayfield Recorder

VEC

Shares of Vectura Group PLC (LON:VEC) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is GBX 125.75 ($1.64). JPMorgan Chase & Co. reduced their target price on Vectura Group from GBX 110 ($1.44) to GBX 100 ($1.31) and set an “overweight” rating for the company in a research report on Wednesday, April 3rd.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Thursday, July 04


News

Vectura Group PLC (LON:VEC) Given Average Rating of “Buy” by Brokerages – Mayfield Recorder

VEC

Shares of Vectura Group PLC (LON:VEC) have earned a consensus rating of “Buy” from the seven brokerages that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is GBX 125.75 ($1.64). Peel Hunt reduced their target price on shares of Vectura Group from GBX 107 ($1.40) to GBX 105 ($1.37) and set a “hold” rating for the company in a research note on Tuesday, March 12th.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Saturday, June 29


News

Vectura Group PLC (LON:VEC) Given Consensus Recommendation of “Buy” by Analysts – Mayfield Recorder

VEC

Shares of Vectura Group PLC (LON:VEC) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is GBX 125.75 ($1.64). JPMorgan Chase & Co. reduced their target price on Vectura Group from GBX 110 ($1.44) to GBX 100 ($1.31) and set an “overweight” rating for the company in a research report on Wednesday, April 3rd.

Read Full Details

Topics:
  • Business
  • Financial
  • Health

Monday, June 17


News

Vectura Group (LON:VEC) Receives Buy Rating from Numis Securities – Rockland Register

VEC

Finally, JPMorgan Chase & Co. cut their target price on Vectura Group from GBX 110 ($1.44) to GBX 100 ($1.31) and set an overweight rating on the stock in a research report on Wednesday, April 3rd. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Shares of LON VEC traded up GBX 0.40 ($0.01) during midday trading on Friday, reaching GBX 81.40 ($1.06). Vectura Group has a 52 week low of GBX 65.85 ($0.86) and a 52 week high of GBX 90.15 ($1.18).

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Sunday, June 16


News

Morgan Stanley Reiterates “Equal Weight” Rating for Cincinnati Bell (NYSE:CBB) – Rockland Register

VEC MS

Cincinnati Bell (NYSE:CBB)‘s stock had its “equal weight” rating reiterated by stock analysts at Morgan Stanley in a note issued to investors on Friday, June 7th, FirstToMarketsRatingsTable reports. They presently have a $8.00 price objective on the utilities provider’s stock, down from their previous price objective of $10.00. Separately, ValuEngine upgraded Cincinnati Bell from a “sell” rating to a “hold” rating in a research report on Wednesday, March 20th. The firm’s revenue was up 28.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Cincinnati Bell will post -1.13 EPS for the current year.

Read Full Details

Topics:
  • Business
  • Financial
  • Health

Monday, June 10


News

UPDATE 1-Drugmaker Vectura parts ways with CEO Ward-Lilley

VEC

UPDATE 1-Drugmaker Vectura parts ways with CEO Ward-Lilley. June 10 (Reuters) - British drugmaker Vectura Group Plc's chief executive officer James Ward-Lilley will step down at the end of this month, the company said on Monday, saying it had agreed with the industry veteran that a change of leadership was needed. Ward-Lilley, who has been in charge of the company since September 2015, will be replaced by Chief Financial Officer Paul Fry on an interim basis as the company starts looking for a new CEO, Vectura said. "The Board and James have agreed that after four years as CEO it is now time for a new leader to take Vectura through its next phase of development," Vectura Chairman Bruno Angelici said.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, May 21


News

Are Analysts Bullish Vectura Group plc (LON:VEC) After Last Week?

VEC

Among 2 analysts covering Vectura Group PLC (LON:VEC), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. The firm has “Hold” rating by Peel Hunt given on Tuesday, March 12. As per Wednesday, December 19, the company rating was maintained by Peel Hunt. 09/05/2019 Broker: Peel Hunt Rating: Hold Old Target: GBX 105.00 New Target: GBX 119.00 Maintain08/05/2019 Broker: Numis Securities Rating: Buy Old Target: GBX 160.00 Maintain08/05/2019 Broker: Shore Capital Rating: Hold Old Target: GBX 75.00 Maintain07/05/2019 Broker: Peel Hunt Rating: Hold Old Target: GBX 105.00 Maintain02/05/2019 Broker: Peel Hunt Rating: Hold Old Target: GBX 105.00 Maintain03/04/2019 Broker: JP Morgan Rating: Overweight Old Target: GBX 110.00 New Target: GBX 100.00 Maintain02/04/2019 Broker: Peel Hunt Rating: Hold Old Target: GBX 105.00 Maintain26/03/2019 Broker: Shore Capital Rating: Hold Maintain26/03/2019 Broker: Peel Hunt Rating: Hold Old Target: GBX 105.00 Maintain12/03/2019 Broker: Peel Hunt Rating: Hold Old Target: GBX 107.00 New Target: GBX 105.00 Maintain. More recent Vectura Group plc (LON:VEC) news were published by: Medgadget.com which released: “Global Oncolytic Virus Therapy Market Segmentation, Application, Growth Drivers and Trend Analysis in 2018-2023 | – Medgadget” on February 05, 2019.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Tuesday, May 07


News

Peel Hunt Keeps Its Hold Rating on Vectura Group PLC (LON:VEC) Shares Today

VEC

Among 2 analysts covering Vectura Group PLC (LON:VEC), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Peel Hunt maintained Vectura Group plc (LON:VEC) on Monday, November 26 with “Hold” rating. As per Wednesday, April 3, the company rating was maintained by JP Morgan. After $0.73 actual earnings per share reported by Vectura Group plc for the previous quarter, Wall Street now forecasts 6.85 % EPS growth. More news for Vectura Group plc (LON:VEC) were recently published by: Fiercebiotech.com, which released: “Vectura slides after PhIII miss dents hopes of using Flutiform in COPD patients – FierceBiotech” on August 30, 2016.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Vectura wins $89.7m in damages from US patent litigation

VEC GSK

Vectura wins $89.7m in damages from US patent litigation. StockMarketWire.com - Vectura Group confirmed that a US court had found that one of its patents was valid and infringed upon by three of GlaxoSmithKline's Ellipta products. The jury awarded Vectura $89.7m in damages for the period from August 2016 through December 2018, based on a calculation of 3% of US sales of the products. Vectura said it expected to seek application of the 3% royalty to the sales of the infringing products through the end of the patent term in mid-2021.

Read Full Details

Topics:
  • Business
  • Financial
  • Health
  • Science